Significant Ownership of Murchinson Ltd.

Signature - Title
/s/ Marc Bistricer - Marc Bistricer, Chief Executive Officer
Location
Toronto
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Murchinson Ltd..

Follow Filing Activity

Follow Murchinson Ltd. and return when a new Schedule 13D/G filing appears.

This tracks SEC filing changes for this page using existing product update flows.

Sponsored

Significant Ownership of Murchinson Ltd.

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
PTHS Pelthos Therapeutics Inc. Common Stock, par value $0.0001 per share 9.1% $7,840,000 280,000 Murchinson Ltd. 30 Sep 2025

Schedules 13D/G Reported by Murchinson Ltd.:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.